FKARX
Price
$41.33
Change
+$0.48 (+1.18%)
Updated
Sep 11 closing price
Net Assets
4.31B
RGABX
Price
$76.42
Change
+$0.41 (+0.54%)
Updated
Sep 11 closing price
Net Assets
353.07B
Interact to see
Advertisement

FKARX vs RGABX

FKARX vs RGABX Comparison Chart in %
View a ticker or compare two or three
VS
FKARX vs. RGABX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FKARX is a Buy and RGABX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 353B vs. FKARX (4.31B). FKARX (0.00) and RGABX (0.00) have matching dividends . FKARX was incepted earlier than RGABX: FKARX (25 years) vs RGABX (24 years). RGABX (1.38) is less costly to investors than FKARX (1.14). FKARX is a more actively managed with annual turnover of: 39.14 vs. RGABX (32.00). RGABX has a lower initial minimum investment than FKARX: RGABX (250) vs FKARX (1000). RGABX annual gain was more profitable for investors over the last year : -1.94 vs. FKARX (-14.25). RGABX return over 5 years is better than : 5.33 vs. FKARX (-31.32).
FKARXRGABXFKARX / RGABX
Total Expense Ratio1.141.3883%
Annual Report Gross Expense Ratio1.141.3883%
Fund Existence25 years24 years-
Gain YTD6.2978.48974%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.31B353B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year-14.25-1.94736%
Returns for 3 years0.2035.881%
Returns for 5 years-31.325.33-587%
Returns for 10 years34.5186.6240%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTOR0.920.02
+2.64%
Citius Oncology Inc
JBI4.590.02
+0.44%
Janus International Group
EVRG81.620.26
+0.32%
Evergy
AMBA67.86-0.01
-0.01%
Ambarella
NTCL1.93-0.04
-2.03%
Netclass Technology Inc.